help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 33, No. 3 418-423
doi:10.1210/jcem-33-3-418
Copyright © 1971 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DOYLE, M. J.
Right arrow Articles by DINGMAN, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DOYLE, M. J.
Right arrow Articles by DINGMAN, J. F.

Hypersecretion of Arginine Vasopressin in Acromegaly

MICHAEL J. DOYLE1, EZEQUIEL LOPEZ-AMOR2 and J. F. DINGMAN3

Department of Medicine, Peter Bent Brigham Hospital, and Harvard Medical School Boston, Massachusetts 02115

Four of 5 patients with untreated active acromegaly demonstrated prolonged antidiuresis and sustained release of arginine vasopressin (AVP) with nicotine stimulation of the neurohypophysis. This hyperresponsiveness was acutely suppressed by adrenal steroids in 2 subjects. Long-term estrogen treatment restored a normal nicotine response in one patient; another showed improved nicotine response after pituitary X-ray irradiation and a normal response with added estrogen therapy. Three additional active patients in clinical remission with estrogen medication showed normal responses to nicotine. These studies suggest that, in active acromegaly, there is a neurohypophyseal hyperresponsiveness to nicotine which improves with clinical remission of the disease. Since the osmoregulatory responses of the neurohypophysis to dehydration, hemodilution and induced hyperosmolality fell within the expected normal range, it appears to be a selective neurohypophyseal derangement.

Supported by grants from the USPHS (HD 03006) and the William F. Milton Fund of Harvard University. Clinical studies were performed on the Clinical Center of the Peter Bent Brigham Hospital, supported by Grant FR-00031 from the USPHS.

1 This work was done in part during the tenure of a fellowship from the Medical Research Council of Canada.

Present address: Centre Hospitalier Universitaire, Sherbrooke, P. Q., Canada.

2 Supported by a Lederle International Fellowship.

3 Address reprint requests to J. F. Dingman, M.D., Peter Bent Brigham Hospital, 721 Huntington Ave., Boston, Mass. 02115.

Received March 27, 1969.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1971 by The Endocrine Society